(0.84%) 5 060.40 points
(0.79%) 38 203 points
(1.39%) 15 822 points
(0.25%) $79.20
(5.18%) $2.03
(0.28%) $2 317.40
(0.72%) $26.94
(1.21%) $966.45
(-0.05%) $0.933
(-0.38%) $10.99
(-0.04%) $0.798
(-1.40%) $91.96
Live Chart Being Loaded With Signals
Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and manufacture of oral, controlled-release products and generic pharmaceuticals...
Stats | |
---|---|
Šios dienos apimtis | 119 521 |
Vidutinė apimtis | 957 026 |
Rinkos kapitalizacija | 132.21M |
EPS | $0 ( 2024-02-14 ) |
Kita pelno data | ( $0 ) 2024-06-29 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 6.49 |
ATR14 | $0.00200 (1.54%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-29 | Hakim Nasrat A | Buy | 49 534 368 | Common Stock |
2023-12-29 | Hakim Nasrat A | Buy | 0 | |
2023-12-29 | Hakim Nasrat A | Buy | 2 223 147 | Common Stock |
2023-11-22 | Whitnell Jeffrey A | Buy | 547 657 | Common Stock |
2023-11-22 | Caskey Davis S | Buy | 547 657 | Common Stock |
INSIDER POWER |
---|
100.00 |
Last 94 transactions |
Buy: 545 075 953 | Sell: 326 529 955 |
Tūris Koreliacija
Elite Pharmaceuticals, Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Elite Pharmaceuticals, Koreliacija - Valiuta/Žaliavos
Elite Pharmaceuticals, Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $34.16B |
Bruto pelnas: | $16.59B (48.58 %) |
EPS: | $4.35 |
FY | 2023 |
Pajamos: | $34.16B |
Bruto pelnas: | $16.59B (48.58 %) |
EPS: | $4.35 |
FY | 2022 |
Pajamos: | $32.26M |
Bruto pelnas: | $14.80M (45.86 %) |
EPS: | $0.00880 |
FY | 2021 |
Pajamos: | $25.38M |
Bruto pelnas: | $11.87M (46.76 %) |
EPS: | $0.00540 |
Financial Reports:
No articles found.
Elite Pharmaceuticals,
Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and manufacture of oral, controlled-release products and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Products and New Drug Applications for Branded Products. It owns, licenses, and contract manufactures various generic and oral dose pharmaceuticals products, such as Phentermine HCl 37.5mg tablets for the treatment of bariatrics under Adipex-P brand; Phendimetrazine Tartrate 35mg tablets for bariatrics under the Bontril brand; Naltrexone HCl 50mg tablets for the treatment of pains under the Revia brand; and Isradipine 2.5mg and 5mg capsules for cardiovascular diseases. The company also provides Oxycodone HCl immediate release 5mg, 10mg, 15mg, 20mg, and 30mg tablets for pains under Roxycodone brand; Trimipramine Maleate Immediate Release antidepressant capsules under the Surmontil brand; Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Immediate Release tablets for central nervous system diseases under the Adderall brand, as well as Dantrolene Sodium capsules for muscle relaxant under the Dantrium brand; SequestOX, an immediate release Oxycodone with Naltrexone; Loxapine Succinate capsules for treating antipsychotic under the brand Loxapine; Acetaminophen and Codeine Phosphate for the management of mild to moderate pain; and antibiotic products. In addition, it manufactures controlled-release products on a contract basis for third parties in the areas of pain, allergy, bariatric, and infection. Further, the company is developing a range of abuse deterrent opioid products. The company was incorporated in 1997 and is headquartered in Northvale, New Jersey.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.